Novartis AG

(NYSE:NVS)

Latest On Novartis AG (NVS):

Date/Time Type Description Signal Details
2024-03-07 04:57 ESTDividendA dividend of $3.78 has been announced on Feb 12, 2024. It will be paid Nov 30, -0001 with an ex-dividend date of Mar 7, 2024.Neutral
2023-05-27 22:22 ESTNewsWhy 2023 is turning into the year of the healthcare spinoffN/A
2023-05-26 18:42 ESTNewsEMA recommends revoking approval of Novartis' sickle cell disease drug Adakveo in EUN/A
2023-05-25 14:01 ESTNewsNovartis' Sandoz gets EMA review for biosimilar to Amgen's Prolia, XgevaN/A
2023-05-22 14:42 ESTNewsAvrobio up 69% on plans to sell gene therapy program to NovartisN/A
2023-05-15 16:58 ESTNewsNovartis appoints 10-member board for Sandoz unit ahead of spinoffN/A
2023-05-10 09:08 ESTNewsNovartis' Sandoz to use Evotec's technology in pact to develop biosimilarsN/A
2023-05-04 05:49 ESTNewsNovartis' Sandoz inks pact to exclusively sell 6 products in USN/A
2023-05-03 17:23 ESTNewsImmix stock slumps ~20% amid interim data for IMX-110 in colorectal cancerN/A
2023-04-27 12:03 ESTNewsNovartis Cosentyx gets EMA panel backing to treat painful skin disorderN/A
2023-04-26 23:42 ESTNewsNovartis: Valuation Seems FairN/A
2023-04-26 11:33 ESTNewsBristol Myers to acquire viral vector manufacturing site in Illinois from NovartisN/A
2023-04-26 11:33 ESTNewsNovartis' iptacopan improves hemoglobin levels in rare blood disorder trial full dataN/A
2023-04-25 23:21 ESTNewsHot Stocks: Earnings sparked movement in PEP, JBLU, NVS, MCD, BIIB and HALN/A
2023-04-25 11:18 ESTNewsNovartis beats Q1 top and bottom line estimates; raises FY23 outlook & planned spin-off on track for H2N/A
2023-04-25 11:18 ESTNewsNovartis trades higher as Entresto, new drugs drive Q1 revenue, raises FY23 outlookN/A
2023-04-25 11:18 ESTNewsNovartis AG 2023 Q1 - Results - Earnings Call PresentationN/A
2023-04-25 11:18 ESTNewsNovartis: Limited Upside Despite Strong First Quarter Results, Improved GuidanceN/A
2023-04-25 11:17 ESTNewsNovartis AG (NVS) Q1 2023 Earnings Call TranscriptN/A
2023-04-24 23:47 ESTNewsNovartis hits 52-week high as Wall Street awaits Q1 2023 earningsN/A
2023-04-20 15:27 ESTNewsNovartis Kesimpta shows benefit in multiple sclerosis patients in 5-year dataN/A
2023-04-20 15:26 ESTNewsNovartis, BeiGene tislelizumab meets main goal in gastric/esophagus cancer trialN/A
2023-04-19 16:50 ESTNewsAmgen wins appeals court ruling in patent dispute over psoriasis drug OtezlaN/A
2023-04-04 05:38 ESTNewsNovartis Humira biosimilar's high concentration gets approval in EUN/A
2023-03-31 12:40 ESTNewsNovartis' heart drug Entresto gets EMA nod for expanded use in childrenN/A
2023-03-28 14:10 ESTNewsBicycle stock pops on cancer drug discovery pact with Novartis, gets $50M upfrontN/A
2023-03-27 22:52 ESTNewsHot Stocks: ROKU and PINS rises on analyst upgrade; CAT stock and FYBR falls on downgrade; NVS higher on cancer trial successN/A
2023-03-27 22:52 ESTNewsNovartis upgraded to hold at Deutsche Bank following breast cancer drug resultsN/A
2023-03-27 22:51 ESTNewsWhy did Novartis stock go up today? Early breast cancer trial resultsN/A
2023-03-27 07:22 ESTNewsNovartis stock jumps on cancer trial successN/A
2023-03-22 19:34 ESTNewsNovartis Humira biosimilar's high concentration gets FDA approvalN/A
2023-03-22 19:34 ESTNewsNovartis to not go ahead with UK trial of cholesterol therapy Leqvio - reportN/A
2023-03-18 07:31 ESTNewsSangamo down post-market as Novartis, Biogen end collaborationsN/A
2023-03-17 16:30 ESTNewsNovartis Tafinlar Mekinist combo gets FDA approval to treat brain cancer in childrenN/A
2023-03-14 12:27 ESTNewsNovartis begins sale of certain eye care assets - reportN/A
2023-03-13 05:53 ESTNewsNovartis launches CHF10B stock buyback programN/A
2023-03-10 15:52 ESTNewsNovartis' Sandoz to invest $400M to build biosimilar production plant in SloveniaN/A
2023-03-09 04:56 ESTDividendA dividend of $3.47 has been announced on Feb 2, 2023. It will be paid Mar 20, 2023 with an ex-dividend date of Mar 9, 2023.Neutral
2023-03-06 21:20 ESTNewsVoyager stock pops on getting $25M from Novartis under license dealN/A
2023-03-06 21:19 ESTNewsNovartis: Cautiously Optimistic, HoldN/A
2023-03-03 14:06 ESTNewsNovartis files for FDA approval of radioligand facility to ramp up production of PluvictoN/A
2023-02-25 00:14 ESTNewsNovartis ends NASH collaboration with PliantN/A
2023-02-23 21:35 ESTNewsIntellia, Novartis end gene editing partnership for sickle cell diseaseN/A
2023-02-20 15:29 ESTNewsNovartis appoints perfume company Firmenich CEO as chairman-designate of SandozN/A
2023-02-09 03:55 ESTNewsNovartis CEO to lead top U.S. pharma lobbyN/A
2023-02-08 14:42 ESTNewsNovartis, Bayer commit financial aid to quake hit Turkey, Syria as rescue operations continueN/A
2023-02-07 12:29 ESTNewsNovartis' biosimilar of Amgen's bone disorder drugs Prolia, Xgeva gets FDA reviewN/A
2023-02-03 01:25 ESTNewsNovartis drops plans to develop Huntington’s disease candidateN/A
2023-02-01 23:01 ESTNewsNovartis ends plans to develop Cosentyx for another autoimmune conditionN/A
2023-02-01 10:00 ESTNewsNovartis reports mixed Q4 earnings, continue to grow with further core margin expansion; initiates FY23 guidanceN/A

About Novartis AG (NVS):

Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology and dermatology, respiratory, established, and cardiovascular, renal and metabolism medicine products. The Sandoz segment provides active ingredients and finished dosage forms of small molecule pharmaceuticals to third parties across a range of therapeutic areas, as well as finished dosage form anti-infectives. It also provides active pharmaceutical ingredients and intermediates primarily antibiotics; protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran; and an agreement with CureVac to manufacture COVID-19 vaccine candidate CVnCoV. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.

NVS Quotes by TradingView

See Advanced Chart

General

  • Name Novartis AG
  • Symbol NVS
  • Type Common Stock
  • Exchange NYSE
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-General
  • Full Time Employees 105,794
  • Last Split Factor1116:1000
  • Last Split Date2019-04-09
  • Fiscal Year EndDecember
  • IPO Date1991-11-18
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.novartis.com
View More

Valuation

  • Trailing PE 24.24
  • Forward PE 13.44
  • Price/Sales (Trailing 12 Mt.) 3.9
  • Price/Book (Most Recent Quarter) 3.38
  • Enterprise Value Revenue 4.35
  • Enterprise Value EBITDA 12.6
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate $6.37
  • Next Year EPS Estimate $6.79
  • Next Quarter EPS Estimate $1.58
  • Profit Margin 16%
  • Operating Margin 24%
  • Return on Assets 6%
  • Return on Equity 14%
  • Revenue 49.76 billion
  • Earnings Per Share $3.52
  • Revenue Per Share $21.85
  • Gross Profit 35.36 billion
  • Quarterly Earnings Growth 1.9%
View More

Highlights

  • Market Capitalization 192.55 billion
  • EBITDA 17.27 billion
  • PE Ratio 14.23
  • PEG Ratio 2.19
  • Analyst Target Price $104.67
  • Book Value Per Share $25.08
View More

Share Statistics

  • Shares Outstanding 2.26 billion
  • Shares Float 2.11 billion
  • % Held by Insiders <1%
  • % Held by Institutions 10.08%
  • Shares Short 6.7 million
  • Shares Short Prior Month 5.35 million
  • Short Ratio 2.94
View More

Technicals

  • Beta 0.48
  • 52 Week High $94.72
  • 52 Week Low $67.52
  • 50 Day Moving Average 88.18
  • 200 Day Moving Average 88.65
View More

Dividends

  • Forward Annual Dividend Rate $3.2
  • Forward Annual Dividend Yield 3.74%
  • Payout Ratio 58%
  • Dividend Date 2021-03-15
  • ExDividend Date 2021-03-04
  • Dividend Per Share $3.4
  • Dividend Yield 3.78%
View More

Novartis AG (NVS) Dividend Calendar:

Novartis AG pays an annual dividend of $3.2 per share, with a dividend yield of 3.78%.
NVS's last dividend payment was made to shareholders on March 15, 2021.
Novartis AG pays out 58% of its earnings out as a dividend.

Ex-Dividend Date Payment Date Record Date Declared Date Amount
2024-03-072024-04-192024-03-082024-02-12$3.74
2023-03-092023-03-202023-03-102023-02-02$3.47
2022-03-082022-03-172022-03-092022-02-03$3.36
2021-03-042021-03-152021-03-052021-01-26$3.38
2020-03-032020-03-122020-03-042020-01-31$3.04
2019-03-042019-03-132019-03-05$2.83
2018-03-062018-04-252018-03-07$2.94
2017-03-012017-04-202017-03-03$2.72
2016-02-242016-04-152016-02-26$2.72
2015-03-022015-04-202015-03-042015-01-30$2.82
2024-03-070000-00-002024-03-082024-02-12$3.78
2016-02-242016-02-26$2.76

Novartis AG (NVS) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-01-26$13.03 billion$1.34$1.39-3.81%
2020-09-302020-10-27$12.54 billion$1.52$1.454.88%
2020-06-302020-07-21$11.62 billion$1.36$1.332.07%
2020-03-312020-04-28$12.71 billion$1.56$1.3615.02%
2019-12-312020-01-29$12.72 billion$1.32$1.311.01%
2019-09-302019-10-22$12.48 billion$1.41$1.354.61%
2019-06-302019-07-18$12.02 billion$1.34$1.248.5%
2019-03-312019-04-24$11.46 billion$1.21$1.21-0.17%
2018-12-312019-01-30$13.66 billion$1.25$1.30-3.48%
2018-09-302018-10-18$13.12 billion$1.32$1.34-1.78%
2018-06-302018-07-18$13.45 billion$1.29$1.281.08%
2018-03-312018-04-19$12.69 billion$1.28$1.270.79%
2017-12-312018-01-24$12.92 billion$1.21$1.173.84%
2017-09-302017-10-24$12.41 billion$1.29$1.243.81%
2017-06-302017-07-18$12.24 billion$1.22$1.174.59%
2017-03-312017-04-25$11.54 billion$1.13$1.102.28%
2016-12-312017-01-25$12.32 billion$1.12$1.101.42%
2016-09-302016-10-25$12.13 billion$1.23$1.193.28%
2016-06-302016-07-19$12.47 billion$1.23$1.175.2%
2016-03-312016-04-21$11.6 billion$1.17$1.161.22%
2015-12-312016-01-27$12.52 billion$1.12$1.18-5.45%
2015-09-302015-10-27$12.27 billion$1.27$1.31-3.05%
2015-06-302015-07-21$12.69 billion$1.25$1.240.81%
2015-03-312015-04-23$11.96 billion$1.29$1.1017.27%
2014-12-312015-01-27$13.13 billion$1.21$1.210%
2014-09-302014-10-28$13.05 billion$1.37$1.296.2%
2014-06-302014-07-17$13.41 billion$1.34$1.40-4.29%
2014-03-312014-04-24$12.83 billion$1.28$1.33-3.76%
2013-12-312014-01-29$13.44 billion$1.19$1.26-5.56%
2013-09-302013-10-22$12.75 billion$1.25$1.31-4.58%
2013-06-302013-07-17$13.13 billion$1.28$1.29-0.78%
2013-03-312013-04-24$12.77 billion$1.32$1.283.13%
2012-12-312013-01-23$14.83 billion$1.27$1.196.72%
2012-09-302012-10-25$13.81 billion$1.34$1.36-1.47%
2012-06-302012-07-19$14.3 billion$1.38$1.296.98%
2012-03-312012-04-24$13.74 billion$1.27$1.32-3.79%
2011-12-312012-01-25$14.78 billion$1.23$1.202.5%
2011-09-302011-10-25$14.84 billion$1.45$1.51-3.97%
2011-06-302011-07-19$14.92 billion$1.48$1.405.71%
2011-03-312011-04-19$14.03 billion$1.41$1.317.63%
2010-12-312011-01-27$14.2 billion$1.14$1.25-8.8%
2010-09-302010-10-21$12.58 billion$1.27$1.205.83%
2010-06-302010-07-15$11.72 billion$1.20$1.136.19%
2010-03-312010-04-20$12.13 billion$1.44$1.2317.07%
2009-12-312010-01-26$12.93 billion$1.01$1.10-8.18%
2009-09-302009-10-22$11.09 billion$0.92$0.95-3.16%
2009-06-302009-07-16$10.55 billion$0.89$0.854.71%
2009-03-312009-04-23$9.71 billion$0.87$0.870%
2008-12-312009-01-28$10.08 billion$0.66$0.79-16.46%
2008-09-302008-10-20$10.75 billion$0.92$0.95-3.16%
2008-06-302008-07-17$10.73 billion$0.98$0.935.38%
2008-03-312008-04-21$9.91 billion$1.02$0.8914.61%
2007-12-312008-01-17$9.93 billion$0.40$0.73-45.21%
2007-09-302007-10-18$9.61 billion$0.68$0.76-10.53%
2007-06-302007-07-17$9.4 billion$0.83$0.786.41%
2007-03-312007-04-23$9.13 billion$0.92$0.849.52%
2006-12-312007-01-18$9.4 billion$0.70$0.78-10.26%
2006-09-302006-10-19$8.82 billion$0.79$0.763.95%
2006-06-302006-07-17$8.51 billion$0.73$0.79-7.59%
2006-03-312006-04-24$7.67 billion$0.83$0.7116.9%
2005-12-312006-01-19$7.45 billion$0.58$0.71-18.31%
2005-09-302005-10-18$8.42 billion$0.71$0.72-1.39%
2005-06-302005-07-14$7.8 billion$0.70$0.666.06%
2005-03-312005-04-21$7.34 billion$0.64
2004-12-312005-01-20$7.58 billion$0.56$0.60-6.67%
2004-09-302004-10-21$7.06 billion$0.63$0.588.62%
2004-06-302004-07-20$6.97 billion$0.63$0.596.78%
2004-03-312004-04-22$6.64 billion$0.52$0.53-1.89%
2003-12-312004-01-22$6.73 billion$0.55$0.533.77%
2003-09-302003-10-20$6.21 billion$0.52$0.520%
2003-06-302003-07-21$6.2 billion$0.52$0.511.96%
2003-03-312003-04-15$5.72 billion$0.43$0.46-6.52%
2002-12-312003-01-23$7 billion$0.46$0.51-9.86%
2002-09-302002-10-17$5.54 billion$0.47$0.447.11%
2002-06-302002-06-30$6.16 billion$0.50
2002-03-312002-03-31$4.74 billion$0.41
1997-06-301997-09-02$0.79$0.790%
1997-03-311997-04-22$0.52$0.4515.56%

Novartis AG (NVS) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Novartis AG (NVS) Chart:

Novartis AG (NVS) News:

Below you will find a list of latest news for Novartis AG (NVS) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Novartis AG (NVS) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-1747.50CALL0 0193.33TRUE00
2024-05-17500CALL0 0157.46TRUE00
2024-05-17550CALL0 0141.52TRUE00
2024-05-17600CALL0 0123.01TRUE00
2024-05-17650CALL0 095.22TRUE00
2024-05-17700CALL0 089.84TRUE00
2024-05-17750CALL0 080.72TRUE00
2024-05-17800CALL0 063.81TRUE00
2024-05-178513.6CALL0 244.57TRUE00
2024-05-1787.58.21CALL0 2045.54TRUE00
2024-05-17908.85CALL101 54666.14TRUE0.170.02
2024-05-1792.55.3CALL0 185629.3TRUE00
2024-05-17954.8CALL26 264725.66TRUE0.60.14
2024-05-1797.52.68CALL1933 997420.46TRUE0.380.17
2024-05-171001.35CALL163 146119.64FALSE0.250.23
2024-05-171050.22CALL9 263519.49FALSE0.020.1
2024-05-171100.1CALL3 1925.34FALSE00
2024-05-171150.25CALL0 20FALSE00
2024-05-171200.09CALL2 040.47FALSE0.090
2024-05-171250CALL0 00FALSE00
2024-05-171300.05CALL0 5050FALSE00
2024-05-171350.05CALL0 2000FALSE00
2024-05-171400.27CALL1 078.1FALSE0.270
2024-05-171450CALL0 00FALSE00
2024-05-1747.50PUT0 00FALSE00
2024-05-17500PUT0 00FALSE00
2024-05-17550.05PUT0 500FALSE00
2024-05-17600.05PUT0 5000FALSE00
2024-05-17650.05PUT0 20FALSE00
2024-05-17700PUT0 00FALSE00
2024-05-17750.13PUT0 10FALSE00
2024-05-17800.08PUT0 230FALSE00
2024-05-17850.11PUT0 11634.37FALSE00
2024-05-1787.50.15PUT1 15531.15FALSE0.12
2024-05-17900.1PUT15 51423.2FALSE00
2024-05-1792.50.11PUT5 65917.94FALSE-0.09-0.45
2024-05-17950.45PUT2 50516.15FALSE-0.12-0.21
2024-05-1797.50.85PUT59 12315.12FALSE-0.34-0.29
2024-05-171001.9PUT6 7412.97TRUE-0.8-0.3
2024-05-1710510.3PUT0 243.57TRUE00
2024-05-171100PUT0 023.48TRUE00
2024-05-171150PUT0 068.5TRUE00
2024-05-171200PUT0 078.4TRUE00
2024-05-171250PUT0 090.62TRUE00
2024-05-171300PUT0 0100.44TRUE00
2024-05-171350PUT0 0107.76TRUE00
2024-05-171400PUT0 0116.34TRUE00
2024-05-171450PUT0 0128.37TRUE00
2024-06-21500CALL0 0117.77TRUE00
2024-06-21550CALL0 0104.8TRUE00
2024-06-21600CALL0 092.73TRUE00
2024-06-21650CALL0 081.36TRUE00
2024-06-21700CALL0 070.54TRUE00
2024-06-21750CALL0 060.92TRUE00
2024-06-21800CALL0 051.34TRUE00
2024-06-21850CALL0 041.68TRUE00
2024-06-2187.50CALL0 030.51TRUE00
2024-06-219010.2CALL9 16032.13TRUE0.950.1
2024-06-2192.56.85CALL0 8821.91TRUE00
2024-06-21953.65CALL0 325.23TRUE00
2024-06-2197.54CALL13 116922.57TRUE0.40.11
2024-06-211002.6CALL96 14821.19FALSE0.40.18
2024-06-211050.85CALL7 19219.28FALSE0.10.13
2024-06-211100.28CALL1 419.8FALSE0.030.12
2024-06-211150CALL0 023.22FALSE00
2024-06-211200CALL0 00FALSE00
2024-06-211250CALL0 00FALSE00
2024-06-211300CALL0 00FALSE00
2024-06-211350CALL0 00FALSE00
2024-06-211400CALL0 00FALSE00
2024-06-21500PUT0 00FALSE00
2024-06-21550PUT0 00FALSE00
2024-06-21600PUT0 00FALSE00
2024-06-21650PUT0 00FALSE00
2024-06-21700PUT0 00FALSE00
2024-06-21750PUT0 00FALSE00
2024-06-21800.18PUT0 10FALSE00
2024-06-21850PUT0 027.75FALSE00
2024-06-2187.51PUT0 519.84FALSE00
2024-06-21900.52PUT0 11717.76FALSE00
2024-06-2192.50.85PUT0 2616.05FALSE00
2024-06-21951.2PUT0 4214.73FALSE00
2024-06-2197.51.75PUT49 19413.48FALSE-0.4-0.19
2024-06-211002.7PUT59 612TRUE-0.8-0.23
2024-06-211059.5PUT0 13112.62TRUE00
2024-06-211100PUT0 033.19TRUE00
2024-06-211150PUT0 034.78TRUE00
2024-06-211200PUT0 017.22TRUE00
2024-06-211250PUT0 054.96TRUE00
2024-06-211300PUT0 061.19TRUE00
2024-06-211350PUT0 067.04TRUE00
2024-06-211400PUT0 072.55TRUE00
2024-07-1947.50CALL0 0112.3TRUE00
2024-07-19500CALL0 0105.45TRUE00
2024-07-19550CALL0 094.67TRUE00
2024-07-19600CALL0 084.54TRUE00
2024-07-19650CALL0 074.18TRUE00
2024-07-19700CALL0 065.02TRUE00
2024-07-19750CALL0 056.1TRUE00
2024-07-198022.6CALL0 047.82TRUE00
2024-07-198512.25CALL0 3039.43TRUE00
2024-07-1987.512.4CALL0 30637.19TRUE00
2024-07-19909.9CALL0 13533.12TRUE00
2024-07-1992.57.51CALL0 4029.11TRUE00
2024-07-19956.5CALL1 59125.29TRUE6.50
2024-07-1997.54.8CALL134 57223.53TRUE0.60.14
2024-07-191003.49CALL88 61622.73FALSE0.340.11
2024-07-191051.58CALL8 114921.16FALSE0.330.26
2024-07-191100.6CALL1 108920.2FALSE0.60
2024-07-191150.25CALL0 74221.11FALSE00
2024-07-191200.2CALL0 38823.29FALSE00
2024-07-191250.1CALL0 5520FALSE00
2024-07-191300.16CALL0 480FALSE00
2024-07-191350CALL0 00FALSE00
2024-07-191400CALL0 00FALSE00
2024-07-191450CALL0 00FALSE00
2024-07-191500.05CALL0 50FALSE00
2024-07-1947.50PUT0 00FALSE00
2024-07-19500.15PUT0 1240FALSE00
2024-07-19550PUT0 00FALSE00
2024-07-19600PUT0 00FALSE00
2024-07-19650.1PUT0 10FALSE00
2024-07-19700.3PUT0 10136.69FALSE00
2024-07-19750.25PUT0 130FALSE00
2024-07-19800.35PUT0 1529.35FALSE00
2024-07-19850.36PUT0 18324.65FALSE00
2024-07-1987.50.48PUT0 23717.87FALSE00
2024-07-19900.8PUT0 47517.45FALSE00
2024-07-1992.50.89PUT2 57615.89FALSE0.890
2024-07-19951.4PUT10 87114.7FALSE1.40
2024-07-1997.52.13PUT15 54413.26FALSE-0.47-0.18
2024-07-191003.6PUT38 53711.95TRUE-0.3-0.08
2024-07-1910510.55PUT0 18217.17TRUE00
2024-07-1911010.7PUT0 325.78TRUE00
2024-07-1911511.7PUT0 132.23TRUE00
2024-07-1912015.02PUT0 038.17TRUE00
2024-07-1912527PUT0 043.72TRUE00
2024-07-1913023.61PUT0 048.92TRUE00
2024-07-1913528.52PUT0 053.82TRUE00
2024-07-1914033.4PUT0 058.46TRUE00
2024-07-1914547.3PUT0 062.86TRUE00
2024-07-1915043.7PUT0 067.04TRUE00
2024-10-1847.50CALL0 095.14TRUE00
2024-10-18500CALL0 088.29TRUE00
2024-10-18550CALL0 081.59TRUE00
2024-10-18600CALL0 072.69TRUE00
2024-10-18650CALL0 065.57TRUE00
2024-10-18700CALL0 058.62TRUE00
2024-10-18750CALL0 051.14TRUE00
2024-10-188020CALL0 1447.11TRUE00
2024-10-188515.3CALL0 137.58TRUE00
2024-10-1887.50CALL0 031.62TRUE00
2024-10-189012.1CALL0 5033.19TRUE00
2024-10-1892.58.1CALL0 3229.06TRUE00
2024-10-18958.01CALL0 1029.91TRUE00
2024-10-1897.56.3CALL0 12328.46TRUE00
2024-10-181005.7CALL1 23225.58FALSE0.40.08
2024-10-181053.6CALL7 24524.3FALSE0.370.11
2024-10-181101.75CALL0 38322.31FALSE00
2024-10-181151CALL6 50421.37FALSE0.140.16
2024-10-181200CALL0 021.32FALSE00
2024-10-181250.25CALL0 1121.39FALSE00
2024-10-181300CALL0 025.68FALSE00
2024-10-181350CALL0 00FALSE00
2024-10-181400CALL0 00FALSE00
2024-10-181450CALL0 00FALSE00
2024-10-181500CALL0 00FALSE00
2024-10-1847.50PUT0 00FALSE00
2024-10-18500PUT0 00FALSE00
2024-10-18550PUT0 00FALSE00
2024-10-18600PUT0 00FALSE00
2024-10-18650PUT0 00FALSE00
2024-10-18700PUT0 039.27FALSE00
2024-10-18750.45PUT0 3225.36FALSE00
2024-10-18800.48PUT2 11620.56FALSE0.480
2024-10-18850.79PUT1 220017.98FALSE0.790
2024-10-1887.52.35PUT0 9116.7FALSE00
2024-10-18903.1PUT0 34215.47FALSE00
2024-10-1892.52.85PUT0 35714.39FALSE00
2024-10-18954.43PUT0 15013.32FALSE00
2024-10-1897.53.5PUT5 28812.04FALSE00
2024-10-181004.3PUT10 3810.27TRUE4.30
2024-10-181057.8PUT0 30TRUE00
2024-10-1811014.7PUT0 280TRUE00
2024-10-181150PUT0 018.3TRUE00
2024-10-181200PUT0 022.7TRUE00
2024-10-181250PUT0 026.9TRUE00
2024-10-181300PUT0 030.9TRUE00
2024-10-181350PUT0 034.7TRUE00
2024-10-181400PUT0 038.3TRUE00
2024-10-181450PUT0 041.71TRUE00
2024-10-181500PUT0 044.94TRUE00
2025-01-1737.564.93CALL1 00TRUE00
2025-01-17400CALL0 00TRUE00
2025-01-1742.50CALL0 00TRUE00
2025-01-17450CALL0 00TRUE00
2025-01-1747.559.4CALL0 090.44TRUE00
2025-01-175052.6CALL0 1786.39TRUE00
2025-01-17550CALL0 077.95TRUE00
2025-01-176042.5CALL0 070.15TRUE00
2025-01-176538.1CALL0 863.42TRUE00
2025-01-1767.50CALL0 00TRUE00
2025-01-177031.4CALL0 056.41TRUE00
2025-01-1772.517.45CALL2 70TRUE00
2025-01-177531CALL0 150.8TRUE00
2025-01-1777.530.7CALL7 70TRUE00
2025-01-178022.75CALL0 1044.92TRUE00
2025-01-1782.50CALL0 00TRUE00
2025-01-178518.96CALL0 240.7TRUE00
2025-01-1787.511.9CALL0 1936.35TRUE00
2025-01-179014.74CALL1 30035.65TRUE14.740
2025-01-1792.511.8CALL0 15033.56TRUE00
2025-01-179510.58CALL6 8830.37TRUE10.580
2025-01-1797.59.18CALL29 11130.13TRUE9.180
2025-01-171007.3CALL0 39226.05FALSE00
2025-01-171054.7CALL0 66026.62FALSE00
2025-01-171103.4CALL5 64424.49FALSE0.40.13
2025-01-171151.85CALL0 44024.29FALSE00
2025-01-171201CALL0 61022.88FALSE00
2025-01-171250.4CALL0 42524.05FALSE00
2025-01-171300.4CALL0 4750FALSE00
2025-01-171350.65CALL0 2300FALSE00
2025-01-171400.6CALL0 9924.51FALSE00
2025-01-171450.25CALL0 770FALSE00
2025-01-171500.3CALL0 70FALSE00
2025-01-171550.28CALL0 10FALSE00
2025-01-171600.15CALL0 50FALSE00
2025-01-1737.50.2PUT1 2450FALSE00
2025-01-17400PUT0 00FALSE00
2025-01-1742.51PUT0 50FALSE00
2025-01-17450PUT0 00FALSE00
2025-01-1747.50.25PUT0 4900FALSE00
2025-01-17500.2PUT0 110FALSE00
2025-01-17550PUT0 00FALSE00
2025-01-17600.5PUT0 00FALSE00
2025-01-17650.75PUT0 5170FALSE00
2025-01-1767.50.9PUT1 320FALSE00
2025-01-17700.55PUT0 3140FALSE00
2025-01-1772.51.15PUT1 10FALSE00
2025-01-17750.75PUT0 1920FALSE00
2025-01-1777.51.2PUT2 2440FALSE00
2025-01-17801.11PUT0 18017.65FALSE00
2025-01-1782.52.35PUT1 2510FALSE00
2025-01-17851.9PUT0 66714.55FALSE00
2025-01-1787.52.65PUT0 11212.94FALSE00
2025-01-17902.1PUT5 31314.68FALSE2.10
2025-01-1792.52.79PUT0 91313.53FALSE00
2025-01-17953.81PUT0 13012.35FALSE00
2025-01-1797.54.56PUT0 21711.06FALSE00
2025-01-171005.5PUT0 2049.51TRUE00
2025-01-1710510.3PUT0 3960TRUE00
2025-01-1711014.5PUT0 220TRUE00
2025-01-1711517.6PUT0 00TRUE00
2025-01-1712018PUT0 011.66TRUE00
2025-01-1712522.7PUT0 017.32TRUE00
2025-01-1713028.3PUT0 021.6TRUE00
2025-01-171350PUT0 025.41TRUE00
2025-01-171400PUT0 028.88TRUE00
2025-01-171450PUT0 032.09TRUE00
2025-01-171500PUT0 035.08TRUE00
2025-01-171550PUT0 037.89TRUE00
2025-01-171600PUT0 040.54TRUE00
2026-01-1647.50CALL0 071.99TRUE00
2026-01-165054.8CALL0 070.36TRUE00
2026-01-16550CALL0 062.49TRUE00
2026-01-166048CALL0 057.44TRUE00
2026-01-16650CALL0 052.6TRUE00
2026-01-167032.1CALL0 2249.5TRUE00
2026-01-16750CALL0 044.67TRUE00
2026-01-168027.5CALL0 243.35TRUE00
2026-01-168518.62CALL0 2039.22TRUE00
2026-01-1687.517.4CALL0 5335.38TRUE00
2026-01-169016.5CALL0 1135.22TRUE00
2026-01-1692.50CALL0 037.53TRUE00
2026-01-169512.3CALL0 1034.03TRUE00
2026-01-1697.517CALL0 634.46TRUE00
2026-01-1610011.5CALL0 6232.34FALSE00
2026-01-161059.16CALL0 18132.31FALSE00
2026-01-161107.3CALL0 41929.58FALSE00
2026-01-161155.41CALL0 16228.39FALSE00
2026-01-161204.3CALL0 18826.98FALSE00
2026-01-161253.4CALL32 20025.27FALSE3.40
2026-01-161303CALL0 525.7FALSE00
2026-01-161350CALL0 027.9FALSE00
2026-01-161401.85CALL0 2722.67FALSE00
2026-01-161451.53CALL0 3523.79FALSE00
2026-01-161500.8CALL0 623.73FALSE00
2026-01-161550CALL0 031.85FALSE00
2026-01-161600CALL0 024.21FALSE00
2026-01-1647.50.8PUT0 240FALSE00
2026-01-16500PUT0 00FALSE00
2026-01-16550.7PUT0 00FALSE00
2026-01-16600PUT0 00FALSE00
2026-01-16650.95PUT0 521.28FALSE00
2026-01-16701.55PUT0 13720.92FALSE00
2026-01-16752.15PUT0 8518.73FALSE00
2026-01-16803PUT0 74218.4FALSE00
2026-01-16853.2PUT0 45514.56FALSE00
2026-01-1687.53.9PUT0 37313.54FALSE00
2026-01-16904.79PUT0 12313FALSE00
2026-01-1692.55.6PUT0 7412.28FALSE00
2026-01-16956.4PUT0 17812.36FALSE00
2026-01-1697.59.3PUT0 119.84FALSE00
2026-01-161007.5PUT0 39.27TRUE00
2026-01-1610510.9PUT72 2314.47TRUE10.90
2026-01-1611011.83PUT0 00TRUE00
2026-01-1611518.07PUT0 20TRUE00
2026-01-161200PUT0 00TRUE00
2026-01-1612524.7PUT0 00TRUE00
2026-01-1613026PUT0 00TRUE00
2026-01-161350PUT0 00TRUE00
2026-01-161400PUT0 00TRUE00
2026-01-161450PUT0 014.71TRUE00
2026-01-161500PUT0 019.78TRUE00
2026-01-161550PUT0 023.03TRUE00
2026-01-161600PUT0 025.71TRUE00

Latest NVS Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST2$82.55
Jun 13, 2022 7:59 PM EST2$82.55
Jun 13, 2022 7:59 PM EST14$82.55
Jun 13, 2022 7:59 PM EST8$82.53
Jun 13, 2022 7:59 PM EST200$82.54

Novartis AG (NVS) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920080559/0001104659-20-080559-index.htm
2019-11-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000089924319026793/0000899243-19-026793-index.htm
2019-11-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000089924319027115/0000899243-19-027115-index.htm
2020-06-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000089924320017188/0000899243-20-017188-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542119000114/0000925421-19-000114-index.htm
2019-03-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542119000139/0000925421-19-000139-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542119000141/0000925421-19-000141-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542119000143/0000925421-19-000143-index.htm
2019-04-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542119000145/0000925421-19-000145-index.htm
2019-04-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542119000149/0000925421-19-000149-index.htm
2019-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542119000153/0000925421-19-000153-index.htm
2019-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542119000157/0000925421-19-000157-index.htm
2019-04-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542119000179/0000925421-19-000179-index.htm
2020-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542120000228/0000925421-20-000228-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542120000244/0000925421-20-000244-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542120000248/0000925421-20-000248-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542120000254/0000925421-20-000254-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542120000256/0000925421-20-000256-index.htm
2019-12-05SC TO-TTender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1114448/000104746919006660/0001047469-19-006660-index.htm
2020-01-30F-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1114448/000104746920000609/0001047469-20-000609-index.htm
2020-02-11424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1114448/000104746920000795/0001047469-20-000795-index.htm
2020-02-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1114448/000104746920000837/0001047469-20-000837-index.htm
2020-02-14POSASRPost-effective Amendment to an automatic shelf registration statementhttps://www.sec.gov/Archives/edgar/data/1114448/000104746920000872/0001047469-20-000872-index.htm
2019-05-223Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000110465919031228/0001104659-19-031228-index.htm
2019-05-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000110465919032920/0001104659-19-032920-index.htm
2019-05-31SDhttps://www.sec.gov/Archives/edgar/data/1114448/000110465919032999/0001104659-19-032999-index.htm
2019-11-25SC TO-CWritten communication relating to an issuer or third partyhttps://www.sec.gov/Archives/edgar/data/1114448/000110465919066818/0001104659-19-066818-index.htm
2019-11-25SC TO-CWritten communication relating to an issuer or third partyhttps://www.sec.gov/Archives/edgar/data/1114448/000110465919067074/0001104659-19-067074-index.htm
2019-12-19SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1114448/000110465919074076/0001104659-19-074076-index.htm
2019-12-23SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1114448/000110465919075309/0001104659-19-075309-index.htm
2020-01-06SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1114448/000110465920001225/0001104659-20-001225-index.htm
2020-02-12FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920016892/0001104659-20-016892-index.htm
2020-04-30S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920054421/0001104659-20-054421-index.htm
2020-04-30S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920054428/0001104659-20-054428-index.htm
2020-04-30S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920054430/0001104659-20-054430-index.htm
2020-04-30S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920054435/0001104659-20-054435-index.htm
2020-06-01SDhttps://www.sec.gov/Archives/edgar/data/1114448/000110465920068035/0001104659-20-068035-index.htm
2020-06-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920076964/0001104659-20-076964-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920080559/0001104659-20-080559-index.htm
2020-07-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920082864/0001104659-20-082864-index.htm
2020-07-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920084106/0001104659-20-084106-index.htm
2020-08-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920095585/0001104659-20-095585-index.htm
2020-08-19SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920096920/0001104659-20-096920-index.htm
2019-03-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319001715/0001171843-19-001715-index.htm
2019-03-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319001911/0001171843-19-001911-index.htm
2019-03-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319002004/0001171843-19-002004-index.htm
2019-05-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319003156/0001171843-19-003156-index.htm
2019-05-246-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319003609/0001171843-19-003609-index.htm
2019-05-246-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319003610/0001171843-19-003610-index.htm
2019-05-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319003629/0001171843-19-003629-index.htm
2019-06-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319003886/0001171843-19-003886-index.htm
2019-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319004272/0001171843-19-004272-index.htm
2019-07-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319004915/0001171843-19-004915-index.htm
2019-08-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319005727/0001171843-19-005727-index.htm
2019-09-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319005958/0001171843-19-005958-index.htm
2019-09-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319006182/0001171843-19-006182-index.htm
2019-10-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319006290/0001171843-19-006290-index.htm
2019-10-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319006403/0001171843-19-006403-index.htm
2019-10-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319006937/0001171843-19-006937-index.htm
2019-11-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319007057/0001171843-19-007057-index.htm
2019-11-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319007596/0001171843-19-007596-index.htm
2019-11-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319007762/0001171843-19-007762-index.htm
2019-12-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319007956/0001171843-19-007956-index.htm
2019-12-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319008118/0001171843-19-008118-index.htm
2020-01-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320000083/0001171843-20-000083-index.htm
2020-01-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320000619/0001171843-20-000619-index.htm
2020-02-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320001368/0001171843-20-001368-index.htm
2020-03-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320001424/0001171843-20-001424-index.htm
2020-03-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320001840/0001171843-20-001840-index.htm
2020-03-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320002076/0001171843-20-002076-index.htm
2020-03-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320002077/0001171843-20-002077-index.htm
2020-04-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320002294/0001171843-20-002294-index.htm
2020-05-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320003608/0001171843-20-003608-index.htm
2020-06-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320004387/0001171843-20-004387-index.htm
2020-06-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320004563/0001171843-20-004563-index.htm
2020-07-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320004689/0001171843-20-004689-index.htm
2020-08-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320005971/0001171843-20-005971-index.htm
2020-08-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320006020/0001171843-20-006020-index.htm
2020-09-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320006198/0001171843-20-006198-index.htm
2020-09-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320006593/0001171843-20-006593-index.htm
2020-10-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320007068/0001171843-20-007068-index.htm
2019-04-246-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000137036819000028/0001370368-19-000028-index.htm
2019-07-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000137036819000049/0001370368-19-000049-index.htm
2019-10-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000137036819000062/0001370368-19-000062-index.htm
2020-01-2920-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1114448/000137036820000003/0001370368-20-000003-index.htm
2020-01-29IRANNOTICENotice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Acthttps://www.sec.gov/Archives/edgar/data/1114448/000137036820000005/0001370368-20-000005-index.htm
2020-01-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000137036820000007/0001370368-20-000007-index.htm
2020-04-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000137036820000061/0001370368-20-000061-index.htm
2020-07-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000137036820000069/0001370368-20-000069-index.htm
2020-10-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000137036820000086/0001370368-20-000086-index.htm

Novartis AG (NVS) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Novartis AG (NVS). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: < 1%
Institutional Ownership: 1008%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-06-30Bioventures Ltd NovartisInsiderBuy125,000.0017.002,125,000.001,181,258.00https://www.sec.gov/Archives/edgar/data/1114448/000110465920080559/0001104659-20-080559-index.htm
2019-05-28Bioventures Ltd Novartis10% Share HolderBuy168,630.0014.002,360,820.001,769,641.00https://www.sec.gov/Archives/edgar/data/1114448/000110465919032920/0001104659-19-032920-index.htm
2019-04-01Bioventures Ltd Novartis10% Share HolderSell20,610.001.9039,159.002,079,394.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000143/0000925421-19-000143-index.htm
2019-03-29Bioventures Ltd Novartis10% Share HolderSell106,540.001.85197,099.002,100,004.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000143/0000925421-19-000143-index.htm
2019-03-15Bioventures Ltd Novartis10% Share HolderSell43,800.001.9284,096.002,206,544.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000114/0000925421-19-000114-index.htm
2019-03-14Bioventures Ltd Novartis10% Share HolderSell13,800.001.8825,944.002,250,344.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000114/0000925421-19-000114-index.htm
2019-03-13Bioventures Ltd Novartis10% Share HolderSell132,738.002.12281,404.562,264,144.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000114/0000925421-19-000114-index.htm
2020-06-19Bioventures Ltd NovartisInsiderSell1,001,312.008.258,260,824.002,467,961.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000256/0000925421-20-000256-index.htm
2020-06-18Bioventures Ltd NovartisInsiderSell900.009.048,136.003,469,273.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000256/0000925421-20-000256-index.htm
2020-06-17Bioventures Ltd Novartis10% Share HolderSell4,622.009.2742,845.943,470,173.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000254/0000925421-20-000254-index.htm
2020-06-16Bioventures Ltd Novartis10% Share HolderSell8,600.009.3079,980.003,474,795.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000254/0000925421-20-000254-index.htm
2020-06-15Bioventures Ltd Novartis10% Share HolderSell6,164.009.0555,784.203,483,395.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000254/0000925421-20-000254-index.htm
2020-06-12Bioventures Ltd Novartis10% Share HolderSell1,500.009.1913,785.003,489,559.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000248/0000925421-20-000248-index.htm
2020-06-11Bioventures Ltd Novartis10% Share HolderSell7,200.009.2166,312.003,491,059.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000248/0000925421-20-000248-index.htm
2020-06-10Bioventures Ltd Novartis10% Share HolderSell8,532.009.4680,712.723,498,259.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000248/0000925421-20-000248-index.htm
2020-06-09Bioventures Ltd Novartis10% Share HolderSell7,000.009.3865,660.003,506,791.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000244/0000925421-20-000244-index.htm
2020-06-08Bioventures Ltd Novartis10% Share HolderSell5,659.009.6654,665.943,513,791.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000244/0000925421-20-000244-index.htm
2020-06-05Bioventures Ltd Novartis10% Share HolderSell8,652.009.6683,578.323,519,450.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000244/0000925421-20-000244-index.htm
2020-06-04Bioventures Ltd Novartis10% Share HolderSell4,088.009.5539,040.403,528,102.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000228/0000925421-20-000228-index.htm
2020-06-03Bioventures Ltd Novartis10% Share HolderSell5,208.009.7850,934.243,532,190.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000228/0000925421-20-000228-index.htm
2020-06-02Bioventures Ltd Novartis10% Share HolderSell5,669.009.6854,875.923,537,398.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000228/0000925421-20-000228-index.htm
2019-11-12Bioventures Ltd Novartis10% Share HolderBuy250,000.0012.003,000,000.003,543,067.00https://www.sec.gov/Archives/edgar/data/1114448/000089924319027115/0000899243-19-027115-index.htm
2019-04-26Bioventures Ltd Novartis10% Share HolderSell138,704.001.03142,865.124,049,804.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000179/0000925421-19-000179-index.htm
2019-04-25Bioventures Ltd Novartis10% Share HolderSell563,096.001.03579,988.884,188,508.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000179/0000925421-19-000179-index.htm
2019-04-24Bioventures Ltd Novartis10% Share HolderSell16,403.001.0316,895.094,751,604.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000157/0000925421-19-000157-index.htm
2019-04-23Bioventures Ltd Novartis10% Share HolderSell27,554.001.0328,380.624,768,007.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000157/0000925421-19-000157-index.htm
2019-04-22Bioventures Ltd Novartis10% Share HolderSell7,100.000.976,887.004,795,561.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000157/0000925421-19-000157-index.htm
2019-04-15Bioventures Ltd Novartis10% Share HolderSell28,794.000.9928,506.064,802,661.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000153/0000925421-19-000153-index.htm
2019-04-12Bioventures Ltd Novartis10% Share HolderSell30,908.001.0432,144.324,831,455.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000153/0000925421-19-000153-index.htm
2019-04-11Bioventures Ltd Novartis10% Share HolderSell57,438.001.0862,033.044,862,363.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000153/0000925421-19-000153-index.htm
2019-04-10Bioventures Ltd Novartis10% Share HolderSell140,230.001.09152,850.704,919,801.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000149/0000925421-19-000149-index.htm
2019-04-09Bioventures Ltd Novartis10% Share HolderSell32,991.001.0133,320.915,060,031.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000149/0000925421-19-000149-index.htm
2019-04-08Bioventures Ltd Novartis10% Share HolderSell27,525.001.0228,075.505,093,022.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000149/0000925421-19-000149-index.htm
2019-04-05Bioventures Ltd Novartis10% Share HolderSell24,661.001.0225,154.225,120,547.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000145/0000925421-19-000145-index.htm
2019-04-04Bioventures Ltd Novartis10% Share HolderSell47,900.001.0148,379.005,145,208.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000145/0000925421-19-000145-index.htm
2019-04-03Bioventures Ltd Novartis10% Share HolderSell58,033.000.9655,711.685,193,108.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000145/0000925421-19-000145-index.htm
2019-04-02Bioventures Ltd Novartis10% Share HolderSell51,754.000.9750,201.385,251,141.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000141/0000925421-19-000141-index.htm
2019-04-01Bioventures Ltd Novartis10% Share HolderSell116,909.000.95111,063.555,302,895.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000141/0000925421-19-000141-index.htm
2019-03-29Bioventures Ltd Novartis10% Share HolderSell63,100.000.9157,421.005,419,804.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000141/0000925421-19-000141-index.htm
2019-03-28Bioventures Ltd Novartis10% Share HolderSell88,835.000.9483,504.905,482,904.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000139/0000925421-19-000139-index.htm
2019-03-27Bioventures Ltd Novartis10% Share HolderSell50,749.000.9950,241.515,571,739.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000139/0000925421-19-000139-index.htm
2019-03-26Bioventures Ltd Novartis10% Share HolderSell177,762.001.01179,539.625,622,488.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000139/0000925421-19-000139-index.htm